Skip to Main Content

Paper Details

Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging.
Front Med (Lausanne)
1
2022
Author NameAffiliation
Ram??n Campos-OlivasSpanish National Cancer Research Centre (CNIO)
  • 1 - 1

Datasets

Release 1.2